Fidelity Investments
AGN

Fidelity Investments’s Allergan Inc AGN Stock Holding History

Fidelity Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4,541,558
Closed -$965M – 2898
2014
Q4 		$965M Sell
4,541,558
-2,481,677
-35% -$493M 0.13% 175
2014
Q3 		$1.25B Buy
7,023,235
+2,853,352
+68% +$474M 0.17% 124
2014
Q2 		$706M Buy
4,169,883
+461,587
+12% +$71.9M 0.09% 228
2014
Q1 		$460M Buy
3,708,296
+149,963
+4% +$18.3M 0.06% 336
2013
Q4 		$395M Sell
3,558,333
-1,606,655
-31% -$153M 0.06% 361
2013
Q3 		$467M Sell
5,164,988
-2,377,517
-32% -$213M 0.07% 313
2013
Q2 		$635M Buy
+7,542,505
New +$782M 0.1% 216

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Fidelity Investments's AGN Position: Q1 2015 in Review

Fidelity Investments sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 4,541,558 shares — an estimated $965M sold.

Fidelity Investments first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.25B in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Fidelity Investments reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Fidelity Investments sold 4,541,558 Allergan Inc shares in Q1 2015, an estimated $965M.
  • Fidelity Investments first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Fidelity Investments's Allergan Inc position peaked at $1.25B in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Fidelity Investments's 13F filing for Q1 2015, filed 14 May 2015.